New research highlights potential of HIF Inhibition as a therapeutic approach for cancers

Curve Therapeutics, a biotech pioneering an intracellular screening platform addressing complex and challenging disease targets, has announced the publication of an article in the Journal of the American Chemical Society (JACS).